Journal of Gynecologic Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2140313, encodeId=d2bd214031398, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：平均5.4周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Thu Jun 01 14:00:11 CST 2023, time=2023-06-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198684, encodeId=29771198684ac, content=收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed16157580, createdName=ms4000000210206098, createdTime=Wed Mar 02 13:00:07 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196883, encodeId=7fdb119688358, content=这个文章投了三个月都没有分配编辑，而且每个作者都要注册确认，准备撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc855537762, createdName=ms6000001575505885, createdTime=Thu Feb 24 17:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104431, encodeId=0c981104431c0, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104432, encodeId=dc3f1104432c9, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539481, encodeId=cf9a539481ee, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491426, encodeId=0260491426dc, content=该杂志原为韩国妇科肿瘤和阴道镜协会主办，现升级为亚洲妇科肿瘤协会官方杂志，相当于日本的JJCO，该杂志为季刊，主要刊登临床型为主的早期检测、临床治疗试验以及综述等，对宫颈癌早期筛查及HPV治疗方面文章尤其容易中的，出版周期大约半年。2011年IF为1.489，其他年份不详，2005年创刊，2008年被SCI收录。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=docfusl, createdTime=Sat Nov 10 10:48:00 CST 2012, time=2012-11-10, status=1, ipAttribution=)]

2023-06-01 梁丽玲来自浙江省

审稿速度:2.0 | 投稿命中率:25.0
经验分享：平均5.4周

96 0

[GetPortalCommentsPageByObjectIdResponse(id=2140313, encodeId=d2bd214031398, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：平均5.4周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Thu Jun 01 14:00:11 CST 2023, time=2023-06-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198684, encodeId=29771198684ac, content=收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed16157580, createdName=ms4000000210206098, createdTime=Wed Mar 02 13:00:07 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196883, encodeId=7fdb119688358, content=这个文章投了三个月都没有分配编辑，而且每个作者都要注册确认，准备撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc855537762, createdName=ms6000001575505885, createdTime=Thu Feb 24 17:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104431, encodeId=0c981104431c0, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104432, encodeId=dc3f1104432c9, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539481, encodeId=cf9a539481ee, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491426, encodeId=0260491426dc, content=该杂志原为韩国妇科肿瘤和阴道镜协会主办，现升级为亚洲妇科肿瘤协会官方杂志，相当于日本的JJCO，该杂志为季刊，主要刊登临床型为主的早期检测、临床治疗试验以及综述等，对宫颈癌早期筛查及HPV治疗方面文章尤其容易中的，出版周期大约半年。2011年IF为1.489，其他年份不详，2005年创刊，2008年被SCI收录。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=docfusl, createdTime=Sat Nov 10 10:48:00 CST 2012, time=2012-11-10, status=1, ipAttribution=)]

2022-03-02 ms4000000210206098

收个案吗

152 0

[GetPortalCommentsPageByObjectIdResponse(id=2140313, encodeId=d2bd214031398, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：平均5.4周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Thu Jun 01 14:00:11 CST 2023, time=2023-06-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198684, encodeId=29771198684ac, content=收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed16157580, createdName=ms4000000210206098, createdTime=Wed Mar 02 13:00:07 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196883, encodeId=7fdb119688358, content=这个文章投了三个月都没有分配编辑，而且每个作者都要注册确认，准备撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc855537762, createdName=ms6000001575505885, createdTime=Thu Feb 24 17:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104431, encodeId=0c981104431c0, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104432, encodeId=dc3f1104432c9, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539481, encodeId=cf9a539481ee, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491426, encodeId=0260491426dc, content=该杂志原为韩国妇科肿瘤和阴道镜协会主办，现升级为亚洲妇科肿瘤协会官方杂志，相当于日本的JJCO，该杂志为季刊，主要刊登临床型为主的早期检测、临床治疗试验以及综述等，对宫颈癌早期筛查及HPV治疗方面文章尤其容易中的，出版周期大约半年。2011年IF为1.489，其他年份不详，2005年创刊，2008年被SCI收录。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=docfusl, createdTime=Sat Nov 10 10:48:00 CST 2012, time=2012-11-10, status=1, ipAttribution=)]

2022-02-24 ms6000001575505885

这个文章投了三个月都没有分配编辑，而且每个作者都要注册确认，准备撤稿重投

146 0

[GetPortalCommentsPageByObjectIdResponse(id=2140313, encodeId=d2bd214031398, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：平均5.4周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Thu Jun 01 14:00:11 CST 2023, time=2023-06-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198684, encodeId=29771198684ac, content=收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed16157580, createdName=ms4000000210206098, createdTime=Wed Mar 02 13:00:07 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196883, encodeId=7fdb119688358, content=这个文章投了三个月都没有分配编辑，而且每个作者都要注册确认，准备撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc855537762, createdName=ms6000001575505885, createdTime=Thu Feb 24 17:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104431, encodeId=0c981104431c0, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104432, encodeId=dc3f1104432c9, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539481, encodeId=cf9a539481ee, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491426, encodeId=0260491426dc, content=该杂志原为韩国妇科肿瘤和阴道镜协会主办，现升级为亚洲妇科肿瘤协会官方杂志，相当于日本的JJCO，该杂志为季刊，主要刊登临床型为主的早期检测、临床治疗试验以及综述等，对宫颈癌早期筛查及HPV治疗方面文章尤其容易中的，出版周期大约半年。2011年IF为1.489，其他年份不详，2005年创刊，2008年被SCI收录。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=docfusl, createdTime=Sat Nov 10 10:48:00 CST 2012, time=2012-11-10, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

投nature需要什么准备？

150 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140313, encodeId=d2bd214031398, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：平均5.4周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Thu Jun 01 14:00:11 CST 2023, time=2023-06-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198684, encodeId=29771198684ac, content=收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed16157580, createdName=ms4000000210206098, createdTime=Wed Mar 02 13:00:07 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196883, encodeId=7fdb119688358, content=这个文章投了三个月都没有分配编辑，而且每个作者都要注册确认，准备撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc855537762, createdName=ms6000001575505885, createdTime=Thu Feb 24 17:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104431, encodeId=0c981104431c0, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104432, encodeId=dc3f1104432c9, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539481, encodeId=cf9a539481ee, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491426, encodeId=0260491426dc, content=该杂志原为韩国妇科肿瘤和阴道镜协会主办，现升级为亚洲妇科肿瘤协会官方杂志，相当于日本的JJCO，该杂志为季刊，主要刊登临床型为主的早期检测、临床治疗试验以及综述等，对宫颈癌早期筛查及HPV治疗方面文章尤其容易中的，出版周期大约半年。2011年IF为1.489，其他年份不详，2005年创刊，2008年被SCI收录。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=docfusl, createdTime=Sat Nov 10 10:48:00 CST 2012, time=2012-11-10, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？

147 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140313, encodeId=d2bd214031398, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：平均5.4周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Thu Jun 01 14:00:11 CST 2023, time=2023-06-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198684, encodeId=29771198684ac, content=收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed16157580, createdName=ms4000000210206098, createdTime=Wed Mar 02 13:00:07 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196883, encodeId=7fdb119688358, content=这个文章投了三个月都没有分配编辑，而且每个作者都要注册确认，准备撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc855537762, createdName=ms6000001575505885, createdTime=Thu Feb 24 17:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104431, encodeId=0c981104431c0, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104432, encodeId=dc3f1104432c9, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539481, encodeId=cf9a539481ee, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491426, encodeId=0260491426dc, content=该杂志原为韩国妇科肿瘤和阴道镜协会主办，现升级为亚洲妇科肿瘤协会官方杂志，相当于日本的JJCO，该杂志为季刊，主要刊登临床型为主的早期检测、临床治疗试验以及综述等，对宫颈癌早期筛查及HPV治疗方面文章尤其容易中的，出版周期大约半年。2011年IF为1.489，其他年份不详，2005年创刊，2008年被SCI收录。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=docfusl, createdTime=Sat Nov 10 10:48:00 CST 2012, time=2012-11-10, status=1, ipAttribution=)]

2017-07-18 chenyuming

3分边缘，希望能维持稳定，略有上升也不错。

342 0

[GetPortalCommentsPageByObjectIdResponse(id=2140313, encodeId=d2bd214031398, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：平均5.4周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL5Br3990UbULuYt9B6QlZqCGMGEyCcoPKW3aUlGTEs4fibqibtjjSdYMCtLHlO300DfNDZExsJPicvA/132, createdBy=500d2427819, createdName=梁丽玲, createdTime=Thu Jun 01 14:00:11 CST 2023, time=2023-06-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1198684, encodeId=29771198684ac, content=收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed16157580, createdName=ms4000000210206098, createdTime=Wed Mar 02 13:00:07 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196883, encodeId=7fdb119688358, content=这个文章投了三个月都没有分配编辑，而且每个作者都要注册确认，准备撤稿重投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bc855537762, createdName=ms6000001575505885, createdTime=Thu Feb 24 17:18:16 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104431, encodeId=0c981104431c0, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104432, encodeId=dc3f1104432c9, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539481, encodeId=cf9a539481ee, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=342, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491426, encodeId=0260491426dc, content=该杂志原为韩国妇科肿瘤和阴道镜协会主办，现升级为亚洲妇科肿瘤协会官方杂志，相当于日本的JJCO，该杂志为季刊，主要刊登临床型为主的早期检测、临床治疗试验以及综述等，对宫颈癌早期筛查及HPV治疗方面文章尤其容易中的，出版周期大约半年。2011年IF为1.489，其他年份不详，2005年创刊，2008年被SCI收录。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=docfusl, createdTime=Sat Nov 10 10:48:00 CST 2012, time=2012-11-10, status=1, ipAttribution=)]

2012-11-10 docfusl

该杂志原为韩国妇科肿瘤和阴道镜协会主办，现升级为亚洲妇科肿瘤协会官方杂志，相当于日本的JJCO，该杂志为季刊，主要刊登临床型为主的早期检测、临床治疗试验以及综述等，对宫颈癌早期筛查及HPV治疗方面文章尤其容易中的，出版周期大约半年。2011年IF为1.489，其他年份不详，2005年创刊，2008年被SCI收录。

557 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务